The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed
Maurizio Bifulco, Michele Ciccarelli, Dario Bruzzese, A. DiPasquale, Andrea Lania, Gherardo Mazziotti, Patrizia Gazzerro
Topics & Concepts
MedicineDiabetes mellitusHydroxymethylglutaryl-CoA Reductase InhibitorsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Prospective cohort studyCoronavirus disease 2019 (COVID-19)Intensive care medicine2019-20 coronavirus outbreakInternal medicineStatinVirologyDiseaseEndocrinologyInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesVitamin C and Antioxidants ResearchLipoproteins and Cardiovascular Health